Trademark Overview
On Monday, November 17, 2025, a trademark application was filed for MERGE LABS with the United States Patent and Trademark Office. The USPTO has given the MERGE LABS trademark a serial number of 99500413. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, November 17, 2025. This trademark is owned by Labs for Humanity, Inc.. The MERGE LABS trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:
Providing online non-downloadable software featuring software that provides a direct interface between the brain and computer systems; software as a service (SAAS) services featuring software that allows users to directly control and communicate with computers using neural activity; providing online non-downloadable software for controlling brain-computer interface (BCI) devices; providing online non-downloadable software and recorded software for interpreting and decoding neural activity; providing online non-downloadable software for identifying biomarkers to train artificial intelligence (AI) and machine learning (ML) systems; research and development in the field of brain-computer interfaces (BCI), direct communication between brain activity and computers, neurostimulation, and therapeutics; providing information in the field of brain-computer interfaces (BCI); gene therapy research; research and development in the field of artificial intelligence (AI) and machine learning (ML) for...
Downloadable and recorded software for providing direct interfaces between the brain and computer systems; downloadable and recorded software for directly controlling and communicating with computers and electronic devices via neural activity; downloadable and recorded software for controlling brain-computer interface (BCI) devices; downloadable and recorded software for interpreting and decoding neural activity; downloadable and recorded software for identifying biomarkers to train artificial intelligence (AI) and machine learning (ML) systems
gene therapy products for enabling and developing brain computer interface (BCI) systems
Brain-computer interface (BCI) devices; implants for directly controlling and communicating with computers and electronic devices via neural activity; devices for opening the blood-brain barrier; computers and electronic devices for directly modulating brain states; devices for detecting brain function